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Neural stem cell (NSC) proliferation and differentiation play a pivotal role in the
development of brain, the plasticity of the brain network, and the repair for brain function
in CNS diseases. The mechanisms regulating NSC behavior are not well elucidated.
Previous studies showed porf-2 functions as a modulator in central nerve system
development. We here show that porf-2, a conserved family of RhoGAPs, is highly and
specifically expressed in NSCs. We also demonstrate that porf-2 inhibits the proliferation
of NSCs in vivo and in vitro, but has no effect on NSC differentiation. We investigated
which domain is required for the role of porf-2 on NSC proliferation. By using neurosphere
formation and Edu assay we confirmed the GAP domain is necessary for its function. In
addition, we surveyed a few classical pathways on NSC proliferation and found that
porf-2 inhibits NSC proliferation by suppressing the β-catenin nuclear translocation.
Taken together, we show for the first time that porf-2 inhibits NSC proliferation through
Wnt/β-catenin pathway by its GAP domain.
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INTRODUCTION
In adult central nervous system (CNS), neural stem cell (NSC) proliferation and differentiation
play a pivotal role in the development of brain, the plasticity of the brain network, and
the repair for brain function in CNS diseases (Kempermann and Gage, 1999; Snyder et al.,
2001; Koehl and Abrous, 2011; Mongiat and Schinder, 2011; Marin-Burgin and Schinder,
2012; Varela-Nallar and Inestrosa, 2013; Bond et al., 2015). The multipotent NSCs are
found mostly in the dentate gyrus (DG) of the hippocampus and the subventricular zone
(SVZ) of the lateral ventricles in adult (Alvarez-Buylla and Garcia-Verdugo, 2002; Zhao
et al., 2008). The NSCs have the capacity for self-renewal and multipotential differentiation
(Reynolds and Weiss, 1992). Once activated, NSCs develop into proliferating intermediate
progenitor cells and the undifferentiated neuroblasts that will finally maturate into neurons,
astrocytes or oligodendrocytes (Reynolds and Weiss, 1992; McKay, 1997; Gage, 2000; Zhao
et al., 2006; Ming and Song, 2011). The new born cells are able to integrate into the
existing neural circuitry and contribute to different brain functions (Deng et al., 2010).
Moreover, NSC transplantation is also a promising therapeutic strategy in several CNS diseases,
including brain and spinal cord injuries, stroke, epilepsy, and neurodegenerative disease
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(Rossi and Cattaneo, 2002; Muller et al., 2006; Nakamura and
Okano, 2013; Burns and Thapar, 2014; Aertker et al., 2015;
Rolfe and Sun, 2015; Tong et al., 2015). Thus elucidating the
molecular mechanism of NSC behavior will help us understand
brain development and provide a platform for future NSCs’
clinical application (Shimazaki, 2003; Selden, 2008).
To coordinate the proper progression of NSC proliferation
and differentiation with preserving the stem cell pool, there
should be a balance between the self-renewal and maintenance
of NSCs and the differentiation. NSC proliferation and
differentiation are a dynamic process and regulated by a
variety of intrinsic and extrinsic factors including growth
factors, cell surface receptors, signal transduction molecules,
and transcription factors (Zhao et al., 2008; Bond et al.,
2015). Several signaling molecules regulate NSC proliferation
and differentiation including PTEN, Wnt, Notch, bone
morphogenetic proteins (BMP), growth and neurotrophic
factors, neurotransmitters, and transcription control (Suh et al.,
2009; Ming and Song, 2011; Hsieh, 2012; Schwarz et al., 2012;
Faigle and Song, 2013). However, our understanding of NSC
behavior is still limited.
Preoptic regulatory factor-2 (Porf-2), also named as
Cross GTPase-activating protein (CrossGAP)/Vilse, was
first discovered from the preoptic area of the hypothalamus
of the castrated male rat (Nowak, 1990, 2003). Nowark et al.
found that porf-2 is widely expressed in diverse tissues including
the CNS and peripheral tissues (Hu and Nowak, 1994; Nowak,
1997, 2003). In the CNS of the rat, it is highly expressed in
the hippocampus, hypothalamus, and cerebral cortex (Hu and
Nowak, 1994; Nowak, 2003). In drosophila, Hu et al. (2005)
reported that porf-2 can directly interact with Roundabout
(Robo) and regulate midline crossing of axon through Rac1-
dependent cytoskeletal changes, which plays a significant role in
the axon development of CNS. Similarly, Lundstrom et al. (2004)
also reported that porf-2 is required for midline repulsion in CNS
of the drosophila. In a recent study of neuronal development
in mice, Lim et al. (2014) reported that porf-2 is involved in
dendritic spine formation through Rac1 pathway. These data
indicated diverse function of porf-2 in CNS. Additionally, in
a study of porf-2 in NSCs, Ma et al. (Ma and Nowak, 2011)
found that porf-2 may play a role in the proliferation of C17.2
cells, a mouse cerebellar multipotent cell line. But the detail
function and mechanism of porf-2 on NSC proliferation and
differentiation has not been elucidated yet.
Porf-2 has three domains: WW domain, Myosin Tail
Homology 4 (Myth4) domain, and GTPase activating proteins
(GAP) domain. The WW domain can bind to the Robo as
reported (Lundstrom et al., 2004; Hu et al., 2005). The function
of Myth4, which may provide a link between an actin-based
motor protein and the microtubules cytoskeleton, is not yet fully
understood (Kerber and Cheney, 2011). The GAP domain is
predicted to transform Rac1/cdc42-GTP status to GDP status
which is inactivated (Tcherkezian and Lamarche-Vane, 2007). But
it still lacks of adequate evidence. Taken together, up to now, the
function of the three domains is still rarely reported.
In the present study, we report that porf-2 is highly
expressed in NSCs. We also demonstrate that porf-2 inhibits the
proliferation of NSCs in vivo and in vitro. In addition it is the
GAP domain that contributes to this phenomenon through the
classical wnt/β-catenin pathway. Taken together, we show for the
first time that porf-2, a conserved family of RhoGAPs, inhibits
NSC proliferation through wnt/β-catenin pathway by its GAP
domain.
MATERIALS AND METHODS
Isolation and Culture of Hippocampus
NSCs
All procedures involving the use of laboratory animals were
approved and monitored by the Animal Care Committee of the
Shanghai Jiao Tong University School of Medicine. NSCs were
isolated from newborn mice at postnatal day 0 or 1 as described
previously (Yang et al., 2014). In brief, the newborn mice were
terminated by decapitation and hippocampus were carefully
dissected, pooled together in a 5ml conical tube containing
1ml dissection buffer (2M NaCl, 1M KCl, 1M MgCl2, 155mM
NaHCO3,1 M Glucose, 108mM CaCl2, 100U/ml Penicillin/100
µg/ml streptomycin) and sliced into small pieces. After 5min of
settling, the supernatant was gently removed and the remaining
tissue was incubated with 1,ml of 0.25% trypsin/0.03% EDTA at
37◦C for 30min followed by one time washing with Dulbecco’s
modified Eagle medium-DMEM/F12 (1:1) medium. After gentle
trituration with a 1ml pipette, the cell suspension was settled
for 5,min, and carefully transferred to a new 15mL tube. After
centrifugation at 500 g for 5min at room temperature (RT) and
removal of the supernatant, the cell pellets were resuspended
in 1ml of complete NSCs medium, DMEM/F12 (1:1) medium
supplemented with 1 × B27 (Gibco, 17504), 1 × N2(Gibco,
17502-048), plus 100U/ml penicillin, 100 µg/ml streptomycin
(Gibco, 15140-122), and basic fibroblast growth factor (bFGF)
(20 ng/ml, R&D), epidermal growth factor (EGF; 20 ng/ml,
R&D). NSCs were cultured for 4–5 days in the complete NSCs
medium and formed neurospheres. When they reached 100–
150 µm in diameter, the NSCs spheres were dissociated using
0.25% trypsin at 37◦C and re-passaged. The experiments were
performed using passage 3–6 neurospheres. Depending on the
type of experiment, 1 to 2 × 105 single cells in 2ml of complete
NSCs medium were plated into each well of a 6-well plate or 0.5–
1 × 103 cells in 500 ul of complete NSCs medium were plated
into each well of a 24-well plate.
Differentiation and Proliferation of NSCs
For the differentiation experiment, the dissociated single NSCs
suspension was plated in 24-well cell culture chambers, which
had been coated by poly-D-lysine (Sigma-Aldrich, P7886) and
6 µg/mL laminin (Sigma-Aldrich, L4544). Then the cells were
cultured for 7 days in the differentiating medium composed
of NeurobasalA (Gibco, 10888) supplemented with 1 × B27
and 1% FBS. The differentiated cells were fixed for 30 min
at room temperature in 4% paraformaldehyde (PFA) prior
to immunostaining using antibodies specific for β-tubulin III
(Tuj1; 1:1000, beyotime, AT809), glial fibrillary acidic protein
(GFAP; 1:3000, Millipore, AB5806), and staining of nuclei with
4′,6-diamidino-2-phenylindole (DAPI). Each experiment average
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percentage of positive cells was calculated on randomly selected
six fields of photograph.
To determine the proliferation of NSCs, Edu labeling
was performed using a Click-iT
R©
EdU Alexa Fluor
R©
647
Imaging Kit (Molecular Probes, life technology) according to
the manufacturer’s instructions. Briefly, primary neurospheres
were dissociated into single cells and the dissociated single NSCs
cell suspension was plated onto laminin-coated chamber slides.
After 4 days culture in NSC complete medium, Edu labeling
solution was added into the medium at final concentration of
10 µM. After 30 min incubation, attached NSCs were fixed
with 4%PFA for 30 min, permeabilized, and then incubated
with Click-iT
R©
reaction cocktail 30min at room temperature,
protected from light. Chamber slides were then mounted with
mounting medium with DAPI, and imaged with a confocal laser
scanning microscope. Average percentage of positive cells was
calculated on randomly selected six fields of photograph from
slice. The Edu positive cells were counted by manually.
Immunofluorescence
NSC spheres or the differentiated single neuronal cells on
chamber slides were processed for histology as above. For brain
slice immunofluorescence, after fixation with 4%PFA perfusion
of mice, the brain slices were made for 30 µm per slice. Both
the cells and the brain slice were blocked in 1 × PBS plus
0.3% Triton X-100 and 10% Normal Donkey Serum (Jackson
ImmunoResearch, 122346) for 60min at RT, and followed by
incubation at 4◦C for overnight in primary antibodies (diluted
in blocking buffer). After 3 times washes (10min for each wash)
in 1 × PBS plus 0.1% Triton X-100, the sections or cells were
incubated in the fluorescence-conjugated secondary antibodies
(1:500 dilution in 1× PBS) plus DAPI for 1 hr at RT. After 3 times
washes, the chamber slides were then mounted with mounting
medium and imaged.
Following primary antibodies were used: rabbit anti-Nestin
(marker for NSPCs 1:400, Abcam), goat anti-Doublecortin (Dcx,
marker for neuronal precursor cells, 1:100, Santa Cruz, sc8066),
rabbit anti-Ki67 (1:200, Thermo scientific, RB-1510), rabbit anti-
β-catenin (1:500, Cell Signaling Technology, 8480). Cell nuclei
were stained with DAPI. Images were taken using a fluorescence
microscope and analyzed with Image J.
Appropriate secondary antibodies were used as follows:
donkey anti-mouse IgG conjugated with AlexaFluor 488,
donkey anti-rabbit IgG conjugated with AlexaFluor 594, donkey
anti-goat IgG conjugated with AlexaFluor 488, donkey anti-
rat IgG conjugated with AlexaFluor 594, donkey anti-rabbit
IgG conjugated with AlexaFluor 488, donkey anti-rabbit IgG
conjugated with AlexaFluor 594. All of secondary antibodies
were purchased from Molecular Probes (Life Technologies), and
diluted 1:500 before use.
Domain Deleted DNA Constructs
Porf-2 gene was amplified from hippocampal cDNA by PCR.
Then the porf-2 gene was digested by Xbal1/Not1 enzyme
and constructed to Plv-IRES-ZsGREEN1 vector. As for the
domain deleted plasmid, the 1ww-porf-2 (65-99 amino acid
deleted), 1Myth4-porf-2(717-902 amino acid deleted), 1GAP-
porf-2 (914-1099 amino acid deleted) were also constructed by
PCR and ligased to Plv-IRES-ZsGreen vector. All the plasmids
were packaged into lentivirus. The viruses were generated by co-
transfection of two helper plasmids (pVSVG and pCMV189)
into the packaging cell line HEK293T at a ratio of 5:6:6 pLvx-
porf-2:pVSVG:pCMV189. Viruses were harvested 48 h after
transfection by collecting the medium from transfected cells and
stored at−80◦C.
Western Blotting
Hippocampal regions from mice at different ages were dissected,
homogenized, and solubilized at 4◦C in Cell lysis buffer
(P0013, beyotime) supplemented with 1mM PMSF, 50mM NaF,
1mM Na3VO4 and protease inhibitor. NSCs were collected,
homogenized, and solubilized in the same buffer. The total
protein lysates were separated by SDS-PAGE and analyzed
by western blotting with anti-GAPDH (1:5000, Sigma-Aldrich,
G8795), mouse anti-Nestin (1:1000, Cell Signaling Technology,
4760), goat anti-Doublecortin (1:1000, Santa Cruz, sc8066), anti-
p-PTEN(1:1000, Cell Signaling Technology, 9554s), anti-PTEN
(1:1000, Cell Signaling Technology, 9188s), anti-β-actin (1:5000,
Thermofisher scientific, MA5-15739) anti-p-Akt (1:1000, Cell
Signaling Technology, 4060s), anti-Akt (1:1000, Cell Signaling
Technology,2920s), p-mTOR (1:1000, Cell Signaling Technology,
5536s), anti-mTOR((1:1000, Cell Signaling Technology, 2972s),
PI3K((1:1000, Cell Signaling Technology, 5569s), p-PI3k(1:1000,
Cell Signaling Technology, 4228s), β-catenin (1:1000, Cell
Signaling Technology, 8480), anti-NICD (1:1000, Cell Signaling
Technology, 4147p), anti-HA (1:1000, Cell Signaling Technology,
2367s), anti-Histon H3 (1:3000, Cell Signaling Technology,
4499), anti-tuj1 (1:1000, beyotime, AT809), anti-porf-2 (1:1000,
Santa Cruz Biotechnology, 87186). HRP-conjugated anti-rabbit,
anti-mouse and anti-goat secondary antibodies (A0208, A0216
and A0181) were from beyotime. Analysis of the data was
performed using NIH ImageJ software. The mean density of each
band was normalized to actin or GAPDH signal in the same
sample.
For the nuclear and cytoplasmic protein separated
experiment, the protein in nucleus and cytoplasm were extracted
following the Nuclear and Cytoplasmic Protein Extraction Kit
(P0028, beyotime), then the same as above, the nuclear and
cytoplasmic protein were analyzed by western blotting with
indicated antibody.
ShRNA Viral Production and Infection
The sequence of porf-2 shRNA are as follows: shRNA1: CCC
TTGATTCCTCATGAAT, ShRNA2: CTGCGAGATCTTCAA
GCTA shRNA3: CAAAGTGACACAGCACATA. Negative
Control: TTCTCCGAACGTGTCACGT. All the shRNAs were
constructed into PLKO.1 vector and the lentivirus were packaged
as mentioned above.
The shRNA1 was also constructed to pAKD-CMV-bGlobin-
mCherry-H1-shRNA vector. Packages of AAV9-shRNA viruses
were provided by Obio Technology, Shanghai, China. Viral titers
were 2.4 × 1012 particles/mL for AAV-ShRNA1, 1.3 × 1013
particles/mL for AAV-ShRNA-control.
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For intracranial viral infection, 1 µl of concentrated AAV-
shRNA was injected into the hippocampal DG area of P1 mice
by stereotaxic injection. Six weeks after viral injection, the
infected mice were sacrificed and processed for immunostaining
as described above. The coordinates for the dentate gyrus were as
follows: AP, 1mm; ML, 1mm; and DV, 1.5mm.
Statistical Analysis
All experiments were performed at least three times in triplicate.
The results are presented as mean ± SEM. Statistical differences
were determined by Student’s t-test for two-group comparisons
or ANOVA followed by Tukey’s test for multiple comparisons
among more than two groups.
RESULTS
Porf-2 is Highly and Specifically Expressed
in Hippocampal NSCs In vivo and In vitro
To identify whether porf-2 is expressed in NSCs, we cultured
primary hippocampal NSCs. After 5 days culture, NSCs
grows into neurosphere stage (Figure 1A). Most of cells in
such neuroblasts were immunostained positive for nestin,
a common NSC maker (Figure 1A). Then we performed
immunofluorescence on the cultured NSC neurosphere and
singleNSCwith porf-2 andnestin antibody. Immunofluorescence
assay with these antibodies revealed that endogenous porf-2 is
localized in the nucleus and fiber of the NSCs, as indicated by
its colocalization with nestin (Figure 1B). Consistent with in
vitro study, porf-2 colocalized with nestin in the DG area of the
hippocampus (Figure 1C). Moreover, porf-2 was also expressed
in GFAP+/Sox-2+ cells, further confirming its expression in
NSCs (Figure S1). While, interestingly, there is no localization
of porf-2 with DCX, a progenitor cell maker (Figure 1D).
This indicted that porf-2 is specifically expressed in the NSCs.
To examine the expressing pattern of porf-2 during
development of NSCs, we performed western blot on
hippocampus tissue lysate throughout early postnatal
development. As shown in Figure 1E, porf-2 gradually increased
during development and in a time-dependent manner. Also
the protein level of nestin and DCX gradually decreased
(Figure 1E), which is consistent with the fact that in the early
stage there are more NSCs in DG area. Then we analyzed the
correlation between porf-2 and nestin expression and the result
showed that there was a negative correlation (p < 0.05, r2 =
0.5785; Figure 1F), indicating that porf-2 correlated with nestin
expression during the development. Meanwhile porf-2 had no
correlation with Tuj1 (r2 = 0.078, p > 0.05; Figure 1F). The
contrary expression pattern indicted porf-2 may have a negative
role on the nestin expression. Together these data demonstrate
porf-2 is specifically expressed in the NSCs in vitro and in vivo
and may have a negative correlation with nestin expression.
Knockdown of Porf-2 Promotes NSC
Proliferation, But Has No Effect on NSC
Differentiation In vitro
We have described porf-2 expression pattern. Next, we explored
its function on NSC behavior. Firstly, we performed knockdown
of porf-2 in mouse hippocampal NSCs by using lentiviral-
mediated shRNA delivery. As shown in Figure 2A and Figure S2,
all the shRNAs have a high knockdown efficiency, especially the
shRNA3, about 61% knockdown in protein level (Figure 2A).
Thus we use shRNA3 to investigate the effect of porf-2 on NSCs
for all the subsequent testings.
To assess the role of porf-2 on NSC proliferation, we
performed neurosphere formation assay as described inmethods.
Four days after the lenti-shRNA infection, all NSC neurospheres
were GFP-postive in both groups (Figure 2B). By quantifying
the size of multipotent neurosphere, we found that knockdown
of porf-2 resulted in larger size neurosphere than those of
controls (Figures 2B,C). Moreover, the percentage of large size
neurosphere in shporf-2 group is higher in comparison to
control (Figure 2C). These data indicated that knockdown of
porf-2 can promote NSC proliferation. The effect of porf-2
on NSC proliferation was further measured by the Edu assay.
Consistent with the results in neurosphere assay, knockdown
of porf-2 showed higher number of Edu positive cells than the
control cells, which means NSC proliferation was enhanced by
porf-2 knockdown (Figure 2D). Together, these results indicate
that knockdown of porf-2 has a promoting effect on NSC
proliferation.
To study the possible effect of porf-2 on NSC differentiation,
we induced the cell differentiation in NSC differentiation
medium for 7 days after lenti-shRNA infection. The cells in
single cell layer were then fixed prior to routine histological
process. The NSC differentiation into mature neural cells was
further verified by immunostaining, using antibodies of neural
cell lineagemarkers, including Tuj1 (neurons), GFAP (astrocytes)
and the cell nuclei were labeled with DAPI (Figure 2E). The
percentage of Tuj1 and GFAP labeled cells was calculated and
no significant difference was observed between the two groups
(Figure 2E). Overall, our results suggest that knockdown of
porf-2 can improve NSC proliferation but has no role on NSC
differentiation.
Porf-2 Inhibits NSC Proliferation In vitro
To further demonstrate the role of porf-2 on NSC proliferation,
we overexpressed porf-2 in NSCs. The overexpression of porf-2
was confirmed by WB (Figure 3A). By using the neurosphere
assay, we measured the diameter of NSC sphere and found that
overexpression of porf-2 can significantly reduce the diameter
of NSC sphere compared to control (Figures 3B,C). In the
Edu assay, as shown in Figure 3D, ∼34% NSCs in control
and about 28% NSCs in porf-2 overexpression group were Edu
positive, confirming that overexpression of porf-2 decreased NSC
proliferation. Altogether, our results suggest that overexpression
of porf-2 inhibits NSC proliferation in vitro.
Porf-2 Inhibits NSCs Proliferation through
Its GAP Domain
As porf-2 has three domains: WW, Myth4, and GAP domain,
we tried to find out which domain is required in the NSC
proliferation. Next, we created three domain deleted plasmids
of porf-2. The construct pattern was shown in Figure 4A.
Our western blot result suggested that the three plasmids
were successfully constructed (Figure 4A). In agreement with
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FIGURE 1 | Porf-2 is highly and specifically expressed in hippocampal NSCs in vivo and in vitro. (A) Representative images of neurosphere formation after
culture for 4–5 days. Identification of NSC neurosphere by immunofluorescence with nestin antibody. Scale bar: 50 µm. (B) Colocalization of porf-2 with nestin in
neurosphere and single NSC visualized by immunofluorescence (indicated with white arrow). Scale bar: 50 µm. (C) Expression and colocalization of porf-2 with nestin
visualized by immunolabeling with indicated antibody in DG area of hippocampus of brain slice. The boxes in upper panel are shown at higher magnification in lower
panels. Whtie arrow indicates the colocalization of porf-2 with nestin. Scale bars: 100 µm in the upper panel and 50 µm in the lower panel. (D) No colocalization of
Porf-2 with DCX in DG area. The boxes in upper panel are shown at higher magnification in lower panels. White arrowhead indicates DCX positive cell. Yellow
arrowhead indicates porf-2 positive cell. Scale bars: 50 µm in both upper and lower panels. (E) The expression pattern of porf-2, nestin, DCX, Tuj1 and Rac1 proteins
were analyzed by western blotting of hippocampal lysates at postnatal day 0, 3, 5; 1, 2, 4, and 6 week. The same blot was probed with anti-GAPDH antibody as a
loading control. The symbol * indicates non-specific signal in western blot analysis. Quantification of porf-2, nestin, DCX, Tuj1, and Rac1 protein level at indicated time.
(F) The expression level of porf-2 was correlated with nestin (red dots) but not tuj1 (black dots) during development. (Red dot, r2 = 0.5785, p < 0.05. Black dot, r2 =
0.078, p > 0.05).
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FIGURE 2 | Knockdown of porf-2 increased NSC proliferation but had no effect on NSC differentiation. (A) Knockdown of porf-2 by lenti-shRNA infection
was confirmed by immunoblot analysis in NSCs. ***P < 0.001 vs. shCtrl. (B) Representative image of neurosphere after 4 days culture in lenti-shCtrl and lenti-shporf-2
group. Scale bar: 200 µm. (C) Comparison and Quantification of the diameter of NSC spheres between shCtrl and shporf-2 group after 4 days lentivirus infection. The
percentage of different neurosphere size was quantified (right panel). Data are mean ± SEM (n = 4). *p < 0.05. (D) Representative image of Edu positive cells in shCtrl
and shporf-2 group. Quantification of the percentage of Edu positive cell number in each group. The number of Edu positive cells is normalized to the total cell
number. Scale bar: 100 µm. Data are mean ± SEM (n = 4). **p < 0.01. (E) Confocal images showing the Tuj1 and GFAP positvie cell after 7 days differentiation of
NSCs in each group. Quantification of the percentage of Tuj1 and GFAP positive cell number in shCtrl and shporf-2 group. The number of Tuj1 or GFAP positive cells
is normalized to the total cell number. Scale bar: 100 µm. Data are mean ± SEM (n = 4). NS: no significant difference P > 0.05.
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FIGURE 3 | Porf-2 inhibits NSC proliferation in vitro. (A) Confirming the overexpression of porf-2 protein by immunoblot. (B) The neurosphere morphology in
control and porf-2 overexpression group. Scale bar: 50 µm. (C) Quantification of the diameter of neurosphere in each group. Data are mean ± SEM (n = 3). (D)
Representative image of Edu positive cells in each group. The total NSC number was counted by DAPI. Quantification of the percentage of Edu positive cell number in
each group. Scale bar: 100 µm. Data are mean ± SEM (n = 4). *P < 0.05.
our result above, overexpression of porf-2 showed smaller
neurosphere phenotype compared to control (Figures 4B,C).
Similarly, overexpression of 1ww-porf-2 and 1Myth4-
porf-2 showed smaller neurosphere phenotype compared to
control, which is consistant with porf-2 overexpression. While
interestingly, the diameter of neurosphere in 1GAP-porf-2
group was back to control level, which indicated that the GAP
domain is the functional domain of porf-2 in NSC proliferation
(Figures 4B,C).
In agreement with the above-mentioned neurosphere
formation assay, overexpression of porf-2, 1ww-porf-2, or
1Myth4-porf-2 showed lower percentage of Edu positive
cells in Edu assay, and 1GAP-porf-2 showed no difference in
comparison to control (Figures 4C,D). The result indicated
that 1GAP-porf-2 lost its function on NSC proliferation.
In other words, the GAP domain is required for porf-2’s
function on NSC proliferation. Above all, porf-2 inhibits NSC
proliferation and the GAP domain plays an essential role in this
process.
Porf-2 Inhibits the NSC Proliferation
through Wnt/β-Catenin Pathway
As is well-known, there are a few classical pathways involved
in NSC proliferation: PTEN/PI3k-Akt, Akt-mTOR, Notch, and
Wnt/β-catenin pathway (Liu and Niswander, 2005; Egeland et al.,
2015). To understand the mechanism of how porf-2 inhibited
NSC proliferation, we surveyed above pathways. As shown
in Figure 6A, p-PTEN/PTEN, p-PI3K/PI3K, p-Akt/Akt protein
level remained unchanged after porf-2 overexpression, indicating
that porf-2 had no effect on PTEN/PI3K/Akt pathway. Then we
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FIGURE 4 | The GAP domain is required for the porf-2’s function on NSC proliferation. (A) The construct pattern of the domain deleted plasmid. Verification of
domain deleted plasmid by immunoblot. The same blot was probed with β-actin antibody as a loading control. (B) The morphology of neurosphere in different groups.
Scale bar: 50 µm. (C) Quantification of neurosphere size in each group. *p < 0.05, **p < 0.01. (D) Representative images of Edu positive cells in indicated group.
Quantification of the percentage of Edu positive cell number in each group. Scale bar: 50 µm. Data are mean ± SEM (n = 5). **P < 0.01.
found that although p-mTOR protein level had a slight decrease,
it showed no significant difference with control (Figure 5A). We
also checked the Notch and Wnt/β-catenin pathway and found
that there was no difference in NICD and β-catenin protein level
between overexpression of porf-2 and control group (Figure 5A).
Similar results were obtained when porf-2 was knock down in
NSCs (data not shown).
Given the fact that β-catenin plays a pivotal role in
Wnt/β-catenin pathway by entering into nucleus to mediate
NSCs proliferation, a process known as β-catenin nuclear
translocation (Kahn, 2014; Sun and Hevner, 2014), we analyzed
the effect of porf-2 on the cellular distribution of β-catenin.
The cytoplasm and nucleus proteins were separated as indicated
by GAPDH and HistoneH3 (Figure 5B). Interestingly, we
found that though there was no change of β-catenin in the
cytoplasm, the protein level of β-catenin in nucleus significantly
decreased after porf-2 overexpression, which suggested porf-2
decreased the translocation of β-catenin to nucleus (Figure 5B).
Consistent with the western blot result, we observed that β-
catenin mostly expressed in cytoplasm instead of nucleus after
porf-2 overexpression by immunoflourence (Figure 5C). Also
we investigated the effect of mutant porf-2 plasmids on β-
catenin nuclear translocation. As shown in Figure 5D, the
protein level of β-catenin in nucleus significantly decreased
in 1ww-porf-2 and 1Myth4-porf-2, which is consistant with
porf-2 overexpression, while the protein level of β-catenin in
nucleus in 1GAP-porf-2 group was back to normal. This
suggested that 1GAP-porf-2 domain is responsible for porf-
2′s effect on β-catenin nuclear translocation (Figure 5D).
Based on these findings, we propose that porf-2 can decrease
the nuclear translocation of β-catenin through its GAP
domain.
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FIGURE 5 | Porf-2 inhibits NSC proliferation through wnt/β-catenin pathway. (A) The expression and quantification of p-PTEN, PTEN, p-PI3K, PI3K, p-Akt,
Akt, p-mTOR, mTOR, NICD, and β-catenin protein in control and porf-2 overexpression group. Data are mean ± SEM (n = 3). β-actin was used as a loading control.
(B) The expression and quantification of β-catenin protein in cytoplasm and nucleus in control and porf-2 overexpression group. GAPDH and HistoneH3 were used as
loading controls for protein in cytoplasm and nucleus respectively. **p < 0.01. (C) Confocal microscopy image of β-catenin expression in NSCs after lentivirus
infection. White arrow indicated the expression of β-catenin in nucleus in control group. Blue arrow indicated the expression of β-catenin in nucleus in porf-2
overexpression group. Scale bar: 50 µm. (D) The expression and quantification of β-catenin protein in cytoplasm and nucleus in different groups. Data are mean ±
SEM (n = 3). **p < 0.01.
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FIGURE 6 | Knockdown of porf-2 promotes NSC proliferation in vivo. (A) The expression of AAV-shRNA indicated by mcherry after 6 weeks infection. Scale bar
100 µm. (B) The ki67 staining in brain slice in each group. The white arrow indicated ki67 positive cell. Scale bar: 100 µm. (C) Quantification of ki67 positive cell
number in each group. Data are mean ± SEM (n = 8). ***P < 0.001. (D) Schematic drawing demonstrating a previously uncharacterized mechanism for porf-2 inhibits
NSC proliferation through wnt/β-catenin pathway by its GAP domain.
Knockdown of Porf-2 Promotes NSC
Proliferation In vivo
To further investigate the function of porf-2 onNSC proliferation
in vivo, we took advantage of AAV-mediated shRNA delivery. At
postnatal day 1, the AAV-shRNA was injected into the DG area
of unilateral hippocampus. Six weeks later, the whole ipsilateral
hippocampus area was infected with the AAV virus, indicated
by red fluorescence (Figure 6A). To assess the effect of shporf-
2 on NSC proliferation, the infected brain slices were stained
with an antibody against the proliferation maker ki67. Next we
calculated the ki67 positive cell number in the DG area and
found that the number of ki67 positive cells was higher in shporf-
2 group in comparison to control (Figures 6B, C). Our results
suggest that knockdown of porf-2 can promote NSC proliferation
in vivo.
DISCUSSION
Our study is the first to show that porf-2 is highly and
specifically expressed in hippocampal NSCs. It also palys
a pivotal role in NSC proliferation in vivo and in vitro.
Moreover, our findings clearly indicate that porf-2 inhibits NSCs
proliferation through its GAP domain byWnt/β-catenin pathway
(Figure 6D).
Previous studies showed porf-2 functions as a key modulator
in axon and dendrite spine development. In CNS, porf-2 is
expressed in different regions of brain, hippocampus, cerebral
cortex, hypothalamus, and so on (Hu and Nowak, 1994; Nowak,
1997, 2003). However, whether or not it is expressed in
hippocampal NSCs and its expression pattern are not elucidated.
Here in this study, we took advantage of immunoflourenscence
and western blot to first demonstrate porf-2 is highly expressed in
NSCs and its expression increases in a time-dependent manner.
These findings prompt us to further investigate its function on
NSC behavior.
NSCs are a unique population of cells that exhibit stem
cell properties, including self-renewal, i.e., production of a
large number of progeny, and multipotency, i.e., differentiation
into the three CNS neural lineages (Louis and Reynolds,
2005). Because NSCs have the ability to support neurogenesis
throughout adulthood, they have been viewed as a renewable
source of neural precursors for regenerative transplantation in
various CNS diseases (Horner and Gage, 2000; Teng et al.,
2002). Increasing evidence suggests that NSCs go through
a process of self-renewal, proliferating, and differentiating
into the appropriate lineage when inflammatory damage or
injury occurs in the nervous system (Pluchino and Martino,
2008). In the present study we demonstrate porf-2 can inhibit
NSC proliferation and knockdown of porf-2 promotes NSC
proliferation, which provides us a new insight into neurogenesis.
Unexpectedly, our study showed that porf-2 did not affect
NSC differentiation, that is to say, it isn’t involved in NSC
differentiation into neuron or astrocyte. The possible reason is
that porf-2 is specifically expressed in activating NSCs but not
the later stages indicated by DCX, which means once the NSCs
go into differentiation stage, porf-2 is not expressed any more.
Thus, porf-2 cannot exert its functions.
Ma et al. (Ma and Nowak, 2011) has recently reported that
knockdown of porf-2 induced increased proliferation and drug-
induced apoptosis through p53/p21 pathway in C17.2 cell. But
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Ma’s report on NSC proliferation is based on an artificial stem
cell line (Ma and Nowak, 2011). In addition, the porf-2 protein
reported in Ma’s study is a 65KD peptide (Ma and Nowak,
2011), not the full-length porf-2, which has a few transcripts.
Different with Ma’s study, we focused on the full length of porf-
2 gene, which encodes a 130 kd protein. Instead of studying
stem cell line, we paid attention to cultured hippocampal NSCs
and observed knockdown of porf-2 significantly increased the
size of neurosphere and the number of Edu positive cells. The
results indicated that downexpression of porf-2 promoted NSC
proliferation. Consistent with the down-expression phenotype,
overexpression of porf-2 decreased the size of neurosphere and
the percentage of Edu positive cell number. Moreover, AAV-
shRNA-porf-2 injection increased the ki67 positive cell number
in DG area, which further confirmed the function of porf-2 in
vivo assay.
It is known that porf-2 has three conserved domains. TheWW
domain of porf-2 was reported as a binding domain which can
bind to member receptor robo and scaffold protein CNK2 to
transduce signal pathway tomediate axon and spine development
(Hu et al., 2005; Lim et al., 2014). The MyTH4 domain has been
identified as a conserved domain in the tail domains of several
different unconventional myosins for intracellular trafficking,
cell division, and muscle contraction (Lu et al., 2014). The
GAPs, which enhance the intrinsic GTPase activity, leading to
the inactive state of the GTPase, involved in multiple cellular
process including NSC proliferation (Dasgupta and Gutmann,
2005; Tcherkezian and Lamarche-Vane, 2007). But as for porf-2,
which domain is necessary for its function on NSCs is not clear.
In our in vitro neurosphere formation and Edu assay, we found
that the full-length-porf-2, 1ww-porf-2, the 1Myth4-porf-2 all
showed a smaller size of neurosphere and lower percentage of
Edu positive cell number, while the 1GAP-porf-2 showed no
difference compared to control. Furthermore, compared to full-
length-porf-2 group, the 1GAP-porf-2 showed a larger size of
neurosphere and higher percentage of Edu positive cell number.
The data showed that the GAP domain deleted porf-2 lost its
inhibitory function on NSC proliferation.
The basic action of NSC proliferation is mediated by
several signal pathways: PTEN/Akt, Akt/mTOR, Notch, and
Wnt/β-catenin pathway (Suh et al., 2009). In our study, we
found that porf-2 overexpression didn’t affect the protein
expression of p-PTEN, p-Akt, p-mToR, which implied that
porf-2 may not be involved in PTEN/Akt/mTOR signaling
pathway. The Notch signaling pathway is a highly conserved
cell signaling system involved in NSC proliferation and
differentiation (Yoon and Gaiano, 2005; Louvi and Artavanis-
Tsakonas, 2006; Ables et al., 2011; Homem et al., 2015). Ligand
proteins binding to the extracellular domain of Notch induced
proteolytic cleavage and release of the Notch intracellular
domain (NICD), which translocated to the nucleus to activate
transcription of downstream target genes to mediate NSC
proliferation and differentiation (Louvi and Artavanis-Tsakonas,
2006). We examined the NICD protein level and found
that porf-2 overexpression didn’t affect the NICD expression,
which suggested that porf-2 didn’t affect the Notch signaling
pathway.
Although these above-mentioned signaling pathways
aren’t involved in porf-2′s action on NSC proliferation, we
demonstrated porf-2 inhibits NSC proliferation through
the β-catenin pathway. In present study, we found that
overexpression of porf-2 didn’t affect the total β-catenin
protein level, but reduced the nuclear β-catenin level. By
using immunofluorescence, we also confirmed that porf-2
overexpression suppressed β-catenin nuclear translocation.
Porf-2 has been reported to mediate midline axon guidance by
inactivating Rac1 in the developing stage (Lundstrom et al., 2004;
Hu et al., 2005). It was reported that Rac1 can mediate β-catenin
nuclear translocation (Esufali and Bapat, 2004; Upadhyay et al.,
2008; Wu et al., 2008; Bosco et al., 2010). Moreover porf-2 is
a RhoGAP, which can inactivate Rac1 as reported (Lundstrom
et al., 2004; Hu et al., 2005; Lim et al., 2014). Thus we propose
that porf-2 can mediate β-catenin nuclear translocation through
inactivating Rac1 by its GAP domain. To test this hypothesis,
we deleted the GAP domain and found that the 1GAP-porf-
2 lost its function on β-catenin nuclear translocation. To
further confirm our hypothesis, we performed the Edu assay
to verify the effect of Rac1 DN on NSC proliferation. And
both the Rac1 DN and porf-2 overexpression showed a lower
percentage of Edu positive cell number in comparison to control
(Figure S3), suggesting Rac1 DN and porf-2 overexpression
showed the same phenotype in NSC. Thus, our work revealed
an uncovered mechanism through which porf-2-induced
proliferation impairment takes place by the modulation of
Wnt/β-catenin signaling through its GAP domain, which may
inactivate Rac1 and result in the suppression of β-catenin nuclear
translocation. However, the precise mechanism underlying porf-
2-induced alteration of Wnt/β-catenin signaling needs to be fully
elucidated.
As is reported in previous studies, GABAAR-mediated
transmission regulates multiple steps of adult neurogenesis,
including control of stem/precursor cell proliferation, cell fate
decision, migration of precursor cells, survival of immature
neurons, dendritic growth, and synaptogenesis (Platel et al.,
2007; Ming and Song, 2011; Dieni et al., 2012). In the SGZ,
NSCs respond tonically to GABA via the α5β3γ2 GABAAR
composition to control their quiescent condition (Song et al.,
2012). It is also reported that GABAARs containing the
α4 subunit are expressed in typeI NSCs to control their
proliferation rate (Duveau et al., 2011). Besides, Liu et al.
reported that both the inter-neuron in the stem cell niche
and the neuroblasts itself can release GABA, leading to tonic
GABAAR activation of neural precursors and a decrease in
proliferation (Liu et al., 2005). Still it is not clear how the
signaling through GABAAR is processed in mediating NSC
behavior. Interestingly, in our current study, we uncovered that
a novel RhoGAP protein, porf-2 plays a inhibitory effect on
NSC proliferation, suggesting its intrinsic role in maintaining
stem cell quiescence as well as GABAAR. However, there
are still questions unsolved. What’s the upstream proteins
or signals of porf-2? How is porf-2 regulated in the brain
development or neurogenesis? Is it possible that GABAAR may
function via Porf-2 and Rac1? Further study are needed to
investigate whether porf-2 may serve as a downstream effector
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of GABAAR or other membrane receptors to inhibit NSC
proliferation.
In summary, our study demonstrates for the first time that
porf-2 can inhibit NSC proliferation but has no effect on
neuron/astrocyte differentiation of NSCs. And porf-2 inhibits
NSC growth through its GAP domain by Wnt/β-catenin
pathway. From this point of views, the porf-2 mediated signal
pathway may provide us a new insight into its future applications
in nerve system.
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Figure S1 | Porf-2 is expressed in NSCs of subgranular zone in DG.
Expression of of porf-2, Sox-2, GFAP were visualized by immunolabeling with
indicated antibody in DG area of brain slice. The boxes in left panel are shown at
higher magnification in right panels. The white arrowhead indicated the
colocalization of porf-2 with GFAP+/Sox-2+ cell. Scale bars: 25 µm in the left
panel and 10 µm in the right panel.
Figure S2 | Porf-2 was knocked down by shRNA. Porf-2 knock-down was
confirmed by Western Blot analysis. The symbol∗ indicated the non-specific
band smaller than 120 KD. GAPDH was used as a loading control.
Figure S3 | Rac1 DN showed the same phenotype as Porf-2 expression on
NSC proliferation. Representative image of Edu positive cells in each group. The
total NSC number was counted by DAPI. Quantification of the percentage of Edu
positive cell number in each group. Scale bar: 50 µm. Data are mean ± SEM (n =
4). ∗∗P < 0.01 vs. control.
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